サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684440

創傷ケア用生物製剤の世界市場：製品別・創傷の種類別・エンドユーザー別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Wound Care Biologics Market, By Product, By Wound Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 379 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
創傷ケア用生物製剤の世界市場：製品別・創傷の種類別・エンドユーザー別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年03月07日
発行: AnalystView Market Insights
ページ情報: 英文 379 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

創傷ケア用生物製剤の市場規模は2024年に22億4,565万米ドルとなり、2025年から2032年にかけてCAGR 5.5%で拡大

創傷ケア用生物製剤の市場力学

褥瘡の有病率の増加と生物製剤をベースとした創傷治療に対する意識の高まりが、市場需要を促進する見込み

創傷ケア用生物製剤市場は、慢性創傷の有病率の上昇、バイオテクノロジーの進歩、生物製剤による創傷治療に対する認識など、さまざまな要因によって大きな成長を遂げています。褥瘡や静脈性下腿潰瘍の発生が増加しているため、生物工学的に設計された代用皮膚や羊膜組織製品のような、より効果的な治療オプションが必要とされており、これも市場の成長を後押ししています。世界の糖尿病患者の増加により、糖尿病性足潰瘍が増加しており、生物学的製剤のような高度な創傷治癒ソリューションが必要とされています。国際糖尿病連合（IDF）によると、世界で約5億3,700万人の成人が糖尿病を患っており、この数は今後も増加すると予想されているため、高度な創傷治療に対する需要が高まっています。

バイオテクノロジーの急速な進歩により、治癒を促進し合併症を軽減する次世代の創傷ケア用生物製剤が開発されています。高齢者は褥瘡や組織再生などのリスクが高いため慢性創傷になりやすく、高齢化は市場成長の主な要因です。政府や民間企業は、より効果的で手ごろな価格の創傷ケア用生物製剤を開発するためにバイオテクノロジー研究に投資しています。米国を含む多くの国では、メディケアやメディケイドプログラムのもとで先進的な創傷ケア製品に対する償還が行われており、生物製剤がより利用しやすくなっています。

創傷ケア用生物製剤市場：主な考察

リサーチアナリストの分析によると、世界市場は予測期間（2025-2032年）にCAGR約5.5%で毎年成長すると予測されています。

製品別に見ると生物学的皮膚代替品のセグメントが、高齢者の創傷治癒に対する高い需要により、2024年に最大の市場シェアを示すと予測されました。

創傷の種類別では、褥瘡や糖尿病性足潰瘍などの有病率の高さから、潰瘍分野が2024年に主要な創傷種類分野となりました。

エンドユーザー別では、創傷ケアや外科的ケアなどのニーズが高いことから、2024年には病院セグメントが主要エンドユーザーとなりました。

地域別では、糖尿病診断における先進医療ソリューションの存在により、北米が2024年の主要収益源でした。

創傷ケア用生物製剤市場：セグメンテーション分析

創傷ケア用生物製剤の世界市場は、製品、創傷の種類、エンドユーザー、地域に基づいて区分されます。

製品は、生物学的皮膚代替物と局所剤の2つに分類されます。生物学的皮膚代替物セグメントが市場を独占しています。従来の治療から生物学的製剤や生物工学的組織へのシフトが進んでいることが、このセグメントの需要を促進しています。

市場は創傷の種類によって潰瘍、手術創・外傷性創傷、火傷の3つに分類されます。潰瘍分野は、高齢者における褥瘡の有病率の高さが同分野の成長に寄与しているため、最大のシェアを占めると予想されます。

市場はエンドユーザー別に病院、外来手術センター、その他の3つに分類されます。エンドユーザー別では、病院が最も高いシェアを占めています。糖尿病、手術、火傷の治療に対する需要の高まりが市場成長を補完しています。

創傷ケア用生物製剤市場：地域別分析

創傷ケア用生物製剤市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。北米は創傷ケア用生物製剤市場で大きなシェアを占めているが、その主な理由は高度な医療インフラと慢性創傷の高い有病率にあります。同地域は高齢化が進んでおり、糖尿病の罹患率も増加していることから、高度な創傷ケアソリューションに対する需要が高まっています。アジア太平洋地域は、創傷ケア用生物製剤市場で最も速い成長が見込まれています。患者人口の多さ、糖尿病などの慢性疾患の有病率の増加、医療インフラの改善などの要因が市場成長を後押ししています。ラテンアメリカは創傷ケア用生物製剤の成長機会を提供しており、ブラジルとメキシコが市場をリードしています。

創傷ケア用生物製剤市場：競合情勢

創傷ケア用生物製剤市場は激しい競合が特徴であり、主要企業は革新的な製品の投入と市場拡大のための研究開発に注力しています。市場参入企業は、成長する世界の創傷治療市場に対応するため、製品ラインの充実に注力しています。バイオテクノロジーにおける絶え間ない技術革新により、より効果的な創傷ケア用生物製剤が開発され、治療成績が向上しています。各社は製品ポートフォリオを拡大し市場での存在感を高めるため、提携、合併、買収に取り組んでいます。

目次

第1章 創傷ケア用生物製剤市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 創傷ケア用生物製剤の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 創傷ケア用生物製剤市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 創傷ケア用生物製剤市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 創傷ケア用生物製剤の市場情勢

  • 創傷ケア用生物製剤の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 創傷ケア用生物製剤市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 製品別セグメントシェア分析
    • 生物学的皮膚代替品
    • 外用剤

第8章 創傷ケア用生物製剤市場：創傷の種類別

  • 概要
    • セグメント別シェア分析：創傷の種類別
    • 潰瘍
    • 手術創・外傷性創傷
    • 火傷

第9章 創傷ケア用生物製剤市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院
    • 外来手術センター
    • その他

第10章 創傷ケア用生物製剤市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：創傷ケア用生物製剤業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Smith &Nephew
    • Molnlycke Health Care
    • ConvaTec Group
    • Coloplast
    • 3M Health Care
    • Organogenesis Holdings
    • Integra LifeSciences
    • MiMedx Group
    • PolyNovo
    • Derma Sciences
    • Medline Industries
    • Hollister Incorporated
    • Aroa Biosurgery
    • Kerecis
    • Cresilon
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4871

REPORT HIGHLIGHT

Wound Care Biologics Market size was valued at USD 2,245.65 Million in 2024, expanding to a CAGR of 5.5% from 2025 to 2032.

Wound Care Biologics are advanced medical products derived from natural, biological sources that help facilitate wound healing. They are typically used in treating chronic wounds, burns, ulcers, and surgical wounds that are difficult to heal with conventional treatments.

Wound Care Biologics Market- Market Dynamics

Increasing prevalence of pressure ulcers and awareness about biologics based wound therapies are expected to propel market demand

The Wound Care Biologics Market is experiencing significant growth, driven by various factors, including the rising prevalence of chronic wounds, advancements in biotechnology and awareness about biologics therapies. The occurrence of pressure ulcers and venous leg ulcers has increased, necessitating more effective treatment options like bioengineered skin substitutes and amniotic tissue products which is also boosting market growth. The global increase in diabetes cases has led to a rise in diabetic foot ulcers, which require advanced wound healing solutions like biologics. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide have diabetes, and this number is expected to rise, leading to a higher demand for advanced wound care.

The rapid progress in biotechnology has led to the development of next-generation wound care biologics that accelerate healing and reduce complications. The aging population is a key contributor to market growth, as elderly individuals are more prone to chronic wounds due to high risks of pressure ulcers, tissue regeneration, etc. Governments and private entities are investing in biotechnology research to develop more effective and affordable wound care biologics. Many countries, including the U.S., provide reimbursement for advanced wound care products under Medicare and Medicaid programs, making biologics more accessible.

Wound Care Biologics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2025-2032)

Based on Product segmentation, the biological skin substitutes segment was predicted to show maximum market share in the year 2024, due to high demand from older aged adults for wound healing.

Based on Wound Type segmentation, the ulcers segment was the leading Wound Type segment in 2024, owing to the high prevalence of pressure ulcers and diabetic foot ulcers, etc.

Based on End User segmentation, the hospital segment was the leading End User segment in 2024, owing to the high need for wound care, surgical care, etc.

Based on the region, North America was the leading revenue generator in 2024, owing to the presence of advanced healthcare solutions in diabetic diagnosis.

Wound Care Biologics Market- Segmentation Analysis:

The Global Wound Care Biologics Market is segmented based on Product, Wound Type, End User, and Region.

The market is divided into two categories based on Product: biological skin substitutes and topical agents. The biological skin substitutes segment dominates the market. The growing shift from traditional treatment to biologics, bioengineered tissues is fueling segment demand.

The market is divided into three categories based on the Wound Type: ulcers, surgical & traumatic wounds, and burns. The ulcers segment is expected to hold the largest share due to the high prevalence of pressure ulcers among older adults is contributing to segment growth.

The market is divided into three categories based on End Users: hospitals, ambulatory surgical centers, and others. The hospitals segment holds the highest share of the End User segment. The growing demand for treatment of diabetes, surgeries & burns is supplementing market growth.

Wound Care Biologics Market- Geographical Insights

Across the world, the Wound Care Biologics market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the wound care biologics market, primarily due to its advanced healthcare infrastructure and high prevalence of chronic wounds. The region's aging population and increasing incidence of diabetes contribute to the demand for advanced wound care solutions. The Asia-Pacific region is anticipated to exhibit the fastest growth in the wound care biologics market. Factors such as a large patient population, increasing prevalence of chronic diseases like diabetes, and improving healthcare infrastructure drive market growth. Latin America offers growth opportunities in wound care biologics, with Brazil and Mexico leading the market.

Wound Care Biologics Market- Competitive Landscape:

The wound care biologics market is characterized by intense competition, with key players focusing on research and development to introduce innovative products and expand their market reach. Market players focusing on enhancing product lines to address the growing global wound care market. Continuous innovations in biotechnology have led to more effective wound care biologics, enhancing treatment outcomes. Companies engage in partnerships, mergers, and acquisitions to expand product portfolios and strengthen market presence.

Recent Developments:

In 2024, Cresilon developed Traumagel and algae derived gel which got FDA approval in August 2024.

In 2024, PolyNovo announced its plan to expand its manufacturing capabilities and enhance its product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL WOUND CARE BIOLOGICS MARKET KEY PLAYERS

  • Smith & Nephew
  • Molnlycke Health Care
  • ConvaTec Group
  • Coloplast
  • 3M Health Care
  • Organogenesis Holdings
  • Integra LifeSciences
  • MiMedx Group
  • PolyNovo
  • Derma Sciences
  • Medline Industries
  • Hollister Incorporated
  • Aroa Biosurgery
  • Kerecis
  • Cresilon
  • Others

GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Biological Skin Substitutes
  • Topical Agents

GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE- MARKET ANALYSIS, 2019-2032

  • Ulcers
  • Surgical & Traumatic Wounds
  • Burns

GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • GLOBAL WOUND CARE BIOLOGICS MARKET BY REGION- MARKET ANALYSIS, 2019-2032
  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Wound Care Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Wound Care Biologics Market Snippet by Product
    • 2.1.2. Wound Care Biologics Market Snippet by Wound Type
    • 2.1.3. Wound Care Biologics Market Snippet by End User
    • 2.1.4. Wound Care Biologics Market Snippet by Country
    • 2.1.5. Wound Care Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. Wound Care Biologics Key Market Trends

  • 3.1. Wound Care Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Wound Care Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Wound Care Biologics Market Opportunities
  • 3.4. Wound Care Biologics Market Future Trends

4. Wound Care Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Wound Care Biologics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Wound Care Biologics Market Landscape

  • 6.1. Wound Care Biologics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Wound Care Biologics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Biological Skin Substitutes
    • 7.1.3. Topical Agents

8. Wound Care Biologics Market - By Wound Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Wound Type, 2024 & 2032 (%)
    • 8.1.2. Ulcers
    • 8.1.3. Surgical & Traumatic Wounds
    • 8.1.4. Burns

9. Wound Care Biologics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Others

10. Wound Care Biologics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Wound Care Biologics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Wound Care Biologics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Wound Care Biologics Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Wound Care Biologics Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Wound Care Biologics Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Wound Care Biologics Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Smith & Nephew
    • 11.2.2. Molnlycke Health Care
    • 11.2.3. ConvaTec Group
    • 11.2.4. Coloplast
    • 11.2.5. 3M Health Care
    • 11.2.6. Organogenesis Holdings
    • 11.2.7. Integra LifeSciences
    • 11.2.8. MiMedx Group
    • 11.2.9. PolyNovo
    • 11.2.10. Derma Sciences
    • 11.2.11. Medline Industries
    • 11.2.12. Hollister Incorporated
    • 11.2.13. Aroa Biosurgery
    • 11.2.14. Kerecis
    • 11.2.15. Cresilon
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us